Sai Life Sciences Limited has informed the Exchange regarding a press release dated October 27, 2025, titled "Sai Life Sciences set to double Process R&D capacity with new facility in Hyderabad".
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the stock exchange about a press release announcing a new Process R&D facility in Hyderabad. The new facility is intended to double the company's existing Process R&D capacity. The announcement was dated October 27, 2025, and signals a significant expansion of the company's research infrastructure. Sai Life Sciences operates in the pharmaceutical contract research and development space, and this move strengthens its service offerings in process chemistry and development.
This is a positive growth signal for shareholders, as expanding Process R&D capacity can support higher revenues and stronger client engagement over the medium term. Investors should watch for updates on capex spend, project timelines, and revenue contribution from the expanded facility.